diabetes

Adocia and Lilly’s legal tussle intensifies as diabetes deal goes wrong
Pharmaforum
Mon, 09/3/18 - 12:11 pm
Eli Lilly
Adocia
insulin
diabetes
AstraZeneca improves diabetes pen to maintain its market share
Pharmaforum
Fri, 08/31/18 - 10:52 am
Europe
AstraZeneca
Bydureon BCise
diabetes
injection pen
Boehringer, Lilly diabetes drug Tradjenta succeeds in cardiovascular outcome trial
Pharmaceutical Business Review
Sun, 08/26/18 - 12:00 pm
Boehringer Ingelheim
Eli Lilly
clinical trials
diabetes
Tradjenta
New Therapy Could Reverse Type 1 Diabetes In Humans And Dogs
Forbes
Sat, 08/25/18 - 09:30 pm
type 1 diabetes
animal health
diabetes
collagen
AI And Radar: The Future Of Noninvasive Blood Sugar Monitoring?
Forbes
Fri, 08/24/18 - 11:15 am
diabetes
blood glucose monitoring
devices
artificial intelligence
Novo Nordisk adds to diabetes pipeline with Evotec deal
Fierce Biotech
Thu, 08/23/18 - 10:13 am
Novo Nordisk
Evotec
drug development
small molecule drugs
obesity
diabetes
Allegro Appoints New CEO and Prepares for Ph III Trials for Diabetic Macular Edema Drug
CP Wire
Tue, 08/21/18 - 10:12 am
Allegro
Luminate
diabetic macular edema
clinical trials
diabetes
Tandem launches insulin pump with predictive low glucose suspend feature in US
Drug Delivery Business News
Mon, 08/20/18 - 11:33 am
devices
Tandem Diabetes
t:slim X2
diabetes
insulin pumps
OHSU to Conduct Clinical Trials with Artificial Pancreas Using Xeris' Liquid Glucagon
CP Wire
Fri, 08/17/18 - 09:34 am
XERIS
diabetes
artificial pancreas
devices
clinical trials
Medtronic launches engagement program for diabetes patients
Drug Delivery Business News
Thu, 08/9/18 - 08:20 pm
Medtronic
devices
diabetes
patients
gamification
The $250 Biohack That’s Revolutionizing Life With Diabetes
Bloomberg
Thu, 08/9/18 - 08:08 am
devices
patients
diabetes
artificial pancreas
Medtronic
Abbott Wins Nod for 14 Day Version of Freestyle Libre
Medical Devices and Diagnostics Industry
Mon, 07/30/18 - 11:38 pm
devices
Abbott Labs
Freestyle Libre 14
blood glucose monitoring
diabetes
FDA
Repurposing a GLP-1 diabetes drug to slow Parkinson’s disease
Fierce Biotech
Tue, 07/24/18 - 10:32 am
diabetes
Parkinson's Disease
GLP-1 agonist
AstraZeneca
Byetta
Bydureon
Novo Nordisk
Victoza
Ozempic
Eli Lilly
Trulicity
Peptron
Abbott CEO aims for more than one million Libre users by 2019
Drug Delivery Business News
Thu, 07/19/18 - 11:01 am
Abbott Labs
devices
FreeStyle Libre
diabetes
blood glucose monitoring
Miles White
Medtronic touts one-year data from insulin pump study
Drug Delivery Business News
Tue, 07/10/18 - 10:57 pm
Medtronic
Unitedhealthcare Group
diabetes
insulin pumps
devices
3 Best Diabetes Stocks of 2018 So Far
Motley Fool
Tue, 07/3/18 - 10:12 am
diabetes
Tandem Diabetes
DexCom
Senseonics
CHMP Issues Positive Opinion to Expand Labeling of Jardiance, Synjardy and Glyxambi to Include Positive Effects on Cardiovascular and Renal Outcomes
CP Wire
Mon, 07/2/18 - 10:02 am
CHMP
Boehringer Ingelheim
Eli Lilly
EMA
Jardiance
Synjardy
Glyxambi
diabetes
Sensile, Sanofi, and Verily Form Diabetes Dream Team
Medical Devices and Diagnostics Industry
Thu, 06/28/18 - 11:43 am
diabetes
Verily
Sensile Medical
Sanofi
devices
insulin patch pump
Amgen's Repatha Reduces Bad Cholestrol in Type II Diabetes
NASDAQ.com
Tue, 06/26/18 - 09:47 am
Amgen
Repatha
type 2 diabetes
diabetes
hypercholesterolemia
ADA
ADA: J&J's Invokana and rivals cut heart failure hospitalizations without increasing amputation risk
Fierce Pharma
Mon, 06/25/18 - 09:12 pm
JNJ
Invokana
diabetes
heart failure

Pages